Archived Newsletters
-
02.06.26 -- New Podcast Episodes: Putting Pressure On CDMOs, BoB@JPM, Building Safer CRISPR Medicines For CVD
2/6/2026
02/06/26 Outsourced Pharma Newsletter
-
02.06.26 -- The Metaphoric Rise Of Outsourcing
2/6/2026
02/06/26 Outsourced Pharma Newsletter
-
02.05.26 -- Where Innovation Meets Biomanufacturing Excellence
2/5/2026
02/05/26 Outsourced Pharma Newsletter
-
02.05.26 -- At JP Morgan 2026, Few Showed Up For U.S. Manufacturing
2/5/2026
02/05/26 Outsourced Pharma Newsletter
-
02.04.26 -- End‑To‑End Development, Analytics, And Manufacturing Solutions
2/4/2026
02/04/26 Outsourced Pharma Newsletter
-
02.04.26 -- At JP Morgan 2026, Few Showed Up For U.S. Manufacturing
2/4/2026
02/04/26 Outsourced Pharma Newsletter
-
02.03.26 -- Trading Places: 2025 Intensified CDMOs Recruiting Sponsor Talent
2/3/2026
02/03/26 Outsourced Pharma Newsletter
-
02.02.26 -- STREAM Edition: Data Governance And Regulations For AI Use In GMP With Peter Baker
2/2/2026
02/02/26 Outsourced Pharma Newsletter
-
02.02.26 -- The Top Drug Development Partners Talk A Good Game
2/2/2026
02/02/26 Outsourced Pharma Newsletter
-
01.30.26 -- Trump's Big Pharma Deals Drive CDMO Investments
1/30/2026
01/30/26 Outsourced Pharma Newsletter